News

Kismet Technologies Secures Key Wins in Science and Entrepreneurship

Published on: 02/10/2024

Kismet Technologies Secures Key Wins in Science and Entrepreneurship

Kismet Technologies, a leader in the Cenfluence Life Sciences Cluster, continues to thrive with two recent major achievements that are positioning the company for significant growth. The Orlando-based, female-founded disinfection technologies company is developing nanoparticles to eradicate most bacteria and viruses with a product that toxicity results show to be as safe as water.

Partnerships and Growth
Member News

Kismet Technologies recently announced it has been awarded a prestigious federal Small Business Technology Transfer (STTR) Phase IIB grant from the National Science Foundation (NSF), valued at $500,000. Kismet was one of fewer than five companies nationwide to receive this grant in 2024, a reflection of the NSF’s interest in their cutting-edge technology. This funding will support further research into Kismet’s antimicrobial technology, specifically targeting the highly virulent, multidrug-resistant Candida auris pathogen. Read more about Kismet’s recent grant award here.

Candida auris poses a significant threat to healthcare facilities due to its resistance to multiple drugs and its persistence on surfaces. Kismet’s innovative solution, designed to eradicate the pathogen on both hard and soft surfaces, holds tremendous potential in improving healthcare environments by reducing the risk of spreading this dangerous fungus. With growing concerns about antimicrobial resistance, Kismet’s research is timely and vital for public health.

Kismet co-founder Dr. Christina Drake, a materials science engineer, invented the company’s patent-pending NanoRAD technology, which kills viruses and bacteria as they land on surfaces for months. Inspired by watching a store employee incorrectly use disinfectant during the COVID-19 pandemic, Drake sought to develop an effective disinfectant that would not trigger allergies, like substances such as bleach can. Drake discovered a novel way to synthesize cerium oxide nanoparticles, resulting in the eradication of most of bacteria and viruses within two hours.

The STTR Phase IIB grant, part of America’s Seed Fund, is highly competitive with fewer than 10% of recipients being women-led companies like Kismet. The NSF program supports startups that focus on transforming breakthrough technologies from research labs into commercial products. This funding will enable Kismet to push forward in its mission to revolutionize surface disinfection with their novel antimicrobial technologies.

In addition to the NSF grant, Kismet Technologies also recently achieved a significant entrepreneurial milestone by winning the Orlando regional event of the Startup World Cup. This victory grants Kismet the opportunity to compete for a $1 million investment at the grand finale in San Francisco, representing Orlando on a global stage. This recognition from the Startup World Cup not only validates Kismet’s innovative approach but also positions them among the top emerging companies in the world.

As a Cenfluence cluster member, Kismet has benefited from access to a thriving ecosystem that fosters collaboration, networking, and innovation within the life sciences sector. The support and resources provided by Cenfluence have played a role in Kismet’s upward trajectory.

Learn more about Kismet here.

Discover more about Cenfluence

Cenfluence is a cluster-focused organization that fosters collaboration, innovation, and growth for companies within high-tech sectors, including life sciences, energy+environmental,gaming e-sports+entertainment, learning sciences +human performance and semi-conductors. By connecting members to resources, partnerships, and opportunities, Cenfluence accelerates business development and market expansion while promoting regional economic growth. With a strong commitment to driving innovation, Cenfluence helps its members thrive within a supportive and dynamic ecosystem.

NEWS​

Related News

Open Market Consultation for the search, incorporation and co-creation of new digital technologies based on digital twins for a personalized approach of congenital and complex pathologies

12 Mar 2025
Check out this Open Market Consultation for the search, incorporation and co-creation of new digital technologies based on digital twins for a persona...

Smart Algorithms vs. Breast Cancer: 14 Teams to Develop AI Solutions for Enhancing Breast Cancer Diagnostics in AI4Health.Cro Challenge

12 Mar 2025
In the news piece, readers will learn about the AI4Health.Cro innovation competition that has attracted 14 talented teams to develop AI tools for impr...

Inside The Digital Health & Wellness Summit 2025 at MWC-4YFN: How ECHAlliance members made an impact

11 Mar 2025
Andy Bleaden shares key takeaways from DHWS25 at 4YFN, where ECHAlliance brought members together, showcased ecosystem innovations, and turned convers...
Featured

ECHAlliance Partners with HealthAI to Advance Responsible AI in Healthcare

11 Mar 2025
ECHAlliance partners with HealthAI - The Global Agency for Responsible AI in Health - to strengthen global AI regulation, offering its members opportu...

Schiltron.io: tech-enabled hardware provider to meet the needs of different health and care environments

10 Mar 2025
Schiltron.io offers a versatile and intelligent portfolio of products and services with a range of smart accessories to meet the needs of different he...

Join the AccessCoVE International Cooperation Network

5 Mar 2025
Gnomon’s role in the European Centre of Vocational Excellence in Accessibility (AccessCoVE) is to bring its expertise in the field of software develop...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *